Healio
Healio

Sitemap

September 24, 2014 Articles

Filter by Available Specialty

Filter by specialty

  1. Adult diabetes rates plateau in US
  2. Allergan rejects Valeant reach out, Ackman threatens suit over Salix
  3. Amedica announces second-generation interbody fusion device
  4. Anti-CD19 CAR T cells show promise in chemotherapy-refractory DLBCL
  5. Biguanides, liraglutide reduced CVD risk in type 2 diabetes
  6. Brief intervention may decrease depressive symptoms in adolescents
  7. Choosing Wisely: Tests cardiologists should avoid
  8. Colorectal cancer task force issues optimal bowel prep guidelines for colonoscopy
  9. Corporate warfare
  10. DHA, EPA therapy reduced liver fat percentage in NAFLD patients
  11. DSM releases Dyneema Purity Radiopaque fiber
  12. EoE patients achieved remission with four-food group elimination diet
  13. FDA allows marketing of first test for yeast pathogens
  14. FDA approves Otezla for treatment of plaque psoriasis
  15. FDA competition offers $500,000 for new ideas in Salmonella detection
  16. FDA grants fast track designation to aramchol for NASH
  17. FDA: Glucose monitoring system cleared for use in critical care units
  18. HCV antibody decline associated with RNA clearance in MSM with HIV
  19. HCV tested in space
  20. Higher activity limitations seen with intramedullary nailing after tibial shaft fracture
  21. HPV vaccine initiation, parental awareness influenced by provider
  22. Intestinal blood flow reduced in patients with chronic HF
  23. Lung cancer screening of Medicare-eligible patients associated with greater benefits, risks
  24. Maternal breast milk primary source of postnatal CMV infection
  25. Metformin monotherapy increased risk for low TSH levels
  26. National Lipid Association issues recommendations for dyslipidemia management
  27. Nonagenarians experience expected rates of postoperative mortality after TKA
  28. NovaBay creates advisory board
  29. Novaliq announces positive phase 1 results for dry eye drops
  30. PARACHUTE III: Percutaneous ventricular restoration device safe in patients with ischemic dilated HF
  31. PARTNER I: TAVR delivers mortality benefit, decreases rehospitalization at 5 years
  32. Ramucirumab offered no benefit in metastatic HER-2–negative breast cancer
  33. Responses to online allergy survey fluctuated monthly, seasonally
  34. Screening tests helpful in identification of potential psoriatic arthritis in psoriasis patients
  35. Topical tranexamic acid reduced transfusion rate, cost in primary THA, TKA
  36. Unilateral, bilateral kyphoplasty comparable for osteoporotic vertebral compression fractures
  37. US diabetes rate may be leveling off